Antiviral activity of geneticin against bovine viral diarrhoea virus

Antiviral Chemistry and Chemotherapy

Volumn 19, Issue 1, 2008, Pages 33-40

  Birk, Alexander V ^a   Dubovi, Edward J ^b   Zhang, Xianchao ^a   Szeto, Hazel H ^c  

^a Institute of Hepatitis and Viral Research   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; GENTAMICIN; KANAMYCIN; NONSTRUCTURAL PROTEIN 3; VIRUS PROTEIN; VIRUS RNA; ANTIVIRUS AGENT; DRUG DERIVATIVE; GENTAMICIN C; INTERFERON; KANAMYCIN B; P80 PROTEIN, BOVINE VIRAL DIARRHEA VIRUS; PEPTIDE HYDROLASE; RNA HELICASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOTOXICITY; DOSE RESPONSE; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; CATTLE; CATTLE DISEASE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; KIDNEY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; STRUCTURE ACTIVITY RELATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CELL SURVIVAL; CELLS, CULTURED; DIARRHEA VIRUS 1, BOVINE VIRAL; GENTAMICINS; INTERFERONS; KANAMYCIN; KIDNEY; NEUTRALIZATION TESTS; PEPTIDE HYDROLASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA HELICASES; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 47049100161     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020801900105     Document Type: Article

References (34)

1. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000; 20:17-35.
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285:26-30.
3. Collett MS, Anderson DK, Retzel E. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae. J Gen Virol 1988; 69:2637-2643.
4. Brownlie J, Clarke MC, Howard CJ. Experimental production of fatal mucosal disease in cattle. Vet Rec 1984; 114:535-536.
5. Bolin SR, McClurkin AW, Cutlip RC, Coria MF. Severe clinical disease induced in cattle persistently infected with noncytopathic bovine viral diarrhea virus by superinfection with cytopathic bovine viral diarrhea virus. Am J Vet Res 1985; 46:573-576.
6. Brownlie J. The pathways for bovine virus diarrhoea virus biotypes in the pathogenesis of disease. Arch Virol Suppl 1991; 3:79-96.
7. Buckwold VE, Beer BE, Donis RO. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res 2003; 60:1-15.
8. Danielson KG, Knepper JE, Kittrell FS, Butel JS, Medina D, Durban EM. Clonal populations of the mouse mammary cell line, COMMA-D, which retain capability of morphogenesis in vivo. In vitro Cell Dev Biol 1989; 25:535-543.
9. Santerre RF, Allen NE, Hobbs JN, Jr., Rao RN, Schmidt RJ. Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene 1984; 30:147-156.
10. Mazzio EA, Soliman KF. Glioma cell antioxidant capacity relative to reactive oxygen species produced by dopamine. J Appl Toxicol 2004; 24:99-106.
11. Paeshuyse J, Leyssen P, Mabery E, et al. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J Virol 2006; 80:149-160.
12. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-497.
13. Branza-Nichita N, Durantel D, Carrouee-Durantel S, Dwek RA, Zitzmann N. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers. J Virol 2001 75:3527-3536.
14. Birk AV, Dubovi EJ, Cohen-Gould L, Donis R, Szeto HH. Cytoplasmic vacuolization responses to cytopathic bovine viral diarrhoea virus. Virus Res 2007; 132:76-85.
15. Lai VC, Zhong W, Skelton A, et al. Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virus. J Virol 2000; 74:6339-6347.
16. Bhudevi B, Weinstock D. Fluorogenic RT-PCR assay (TaqMan) for detection and classification of bovine viral diarrhea virus. Vet Microbiol 2001; 83:1-10.
17. Cabanas MJ, Vazquez D, Modolell J. Inhibition of ribosomal translocation by aminoglycoside antibiotics. Biochem Biophys Res Commun 1978; 83:991-997.
18. Eustice DC, Wilhelm JM. Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis. Antimicrob Agents Chemother 1984; 26:53-60.
19. Vassilev VB, Donis RO. Bovine viral diarrhea virus induced apoptosis correlates with increased intracellular viral RNA accumulation. Virus Res 2000; 69:95-107.
20. Ouzounov S, Mehta A, Dwek RA, Block TM, Jordan R. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Res 2002; 55:425-435.
21. Durantel D, Carrouee-Durantel S, Branza-Nichita N, Dwek RA, Zitzmann N. Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus. Antimicrob Agents Chemother 2004; 48:497-504.
22. Benveniste R, Davies J. Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob Agents Chemother 1973; 4:402-409.
23. Vicens Q, Westhof E. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J Mol Biol 2003; 326:1175-1188.
24. Lai CH, Chun HH, Nahas SA, et al. Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci U S A 2004; 101:15676-15681.
25. Konno T, Takahashi T, Kurita D, Muto A, Himeno H. A minimum structure of aminoglycosides that causes an initiation shift of trans-translation. Nucleic Acids Res 2004; 32:4119-4126.
26. Borovinskaya MA, Pai RD, Zhang W, et al. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat Struct Mol Biol 2007; 14:727-732.
27. Borovinskaya MA, Shoji S, Holton JM, Fredrick K, Cate JH. A steric block in translation caused by the antibiotic spectinomycin. ACS Chem Biol 2007; 2:545-552.
28. Langeland N, Haarr L, Holmsen H. Evidence that neomycin inhibits HSV 1 infection of BHK cells. Biochem Biophys Res Commun 1986; 141:198-203.
29. Langeland N, Oyan AM, Marsden HS, et al. Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol 1990; 64:1271-1277.
30. Zapp ML, Stern S, Green MR. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 1993; 74:969-978.
31. Griffiths JK, Balakrishnan R, Widmer G, Tzipori S. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. Infect Immun 1998; 66:3874-3883.
32. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 2000; 48:164-169.
33. Stephenson J. Antibiotics show promise as therapy for genetic disorders. JAMA 2001; 285:2067-2068.
34. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 1999; 104:375-381.